Edmonton Symptom Assessment Scale may reduce medical visits in patients undergoing chemotherapy for breast cancer

Table 2 Outcomes of interest during the chemotherapy treatment in the study population

Variable	Group A (ESAS)	Group B (No ESAS)
N of doctor visit scheduled for each patient	3	16
Total No. of scheduled doctor visits	300	1600
N of patients requiring adjunctive visit on the bases of ESAS score > 3	48	-
N of adjunctive visits on the bases of ESAS score > 3	130	-
N of patients requiring unplanned doctor visits	6	12
N of unplanned doctor visit	8	18
Effective total No. of doctor visitsa	438	1618
N of visits for each patient (mean ± SD)b	4.38 ± 0.51	16.18 ± 1.82
Adverse effects during chemotherapy treatment	2	3

^aP < 0.001.

^bP < 0.001. ESAS: Edmonton Symptom Assessment Scale.